111 related articles for article (PubMed ID: 35879793)
1. Retraction Note: LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.
Huang G; Jiang H; Lin Y; Xia W; Luo Y; Wu Y; Cai W; Zhou X; Jiang X
J Exp Clin Cancer Res; 2022 Jul; 41(1):231. PubMed ID: 35879793
[No Abstract] [Full Text] [Related]
2. LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.
Huang G; Jiang H; Lin Y; Xia W; Luo Y; Wu Y; Cai W; Zhou X; Jiang X
J Exp Clin Cancer Res; 2018 Jun; 37(1):121. PubMed ID: 29925408
[TBL] [Abstract][Full Text] [Related]
3. LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.
Shao M; Yang Q; Zhu W; Jin H; Wang J; Song J; Kong Y; Lv X
Mol Cancer; 2018 Dec; 17(1):173. PubMed ID: 30545354
[TBL] [Abstract][Full Text] [Related]
4. Retraction:
Li X; Li M; Chen J; Dai H; Wang L; Xiong Y; Zhong Y; Zhang L
Oncotarget; 2022 Nov; 13():1201. PubMed ID: 36322426
[No Abstract] [Full Text] [Related]
5. LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
Chen Z; Gao Y; Yao L; Liu Y; Huang L; Yan Z; Zhao W; Zhu P; Weng H
Oncogene; 2018 Jun; 37(23):3098-3112. PubMed ID: 29535420
[TBL] [Abstract][Full Text] [Related]
6. Correction to: LncMAPK6 drives MAPK6 expression and liver TIC self-renewal.
Huang G; Jiang H; He Y; Lin Y; Xia W; Luo Y; Liang M; Shi B; Zhou X; Jian Z
J Exp Clin Cancer Res; 2019 Dec; 38(1):500. PubMed ID: 31861994
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling.
Wu J; Zhu P; Lu T; Du Y; Wang Y; He L; Ye B; Liu B; Yang L; Wang J; Gu Y; Lan J; Hao Y; He L; Fan Z
J Hepatol; 2019 May; 70(5):918-929. PubMed ID: 30582981
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling.
Gu Y; Wang Y; He L; Zhang J; Zhu X; Liu N; Wang J; Lu T; He L; Tian Y; Fan Z
Mol Cancer; 2021 Oct; 20(1):132. PubMed ID: 34649567
[TBL] [Abstract][Full Text] [Related]
9. Retraction Note: LncMAPK6 drives MAPK6 expressionand liver TIC self-renewal.
Huang G; Jiang H; He Y; Lin Y; Xia W; Luo Y; Liang M; Shi B; Zhou X; Jian Z
J Exp Clin Cancer Res; 2022 Oct; 41(1):308. PubMed ID: 36266670
[No Abstract] [Full Text] [Related]
10. Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF.
Chen Z; Lu T; Huang L; Wang Z; Yan Z; Guan Y; Hu W; Fan Z; Zhu P
J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34403373
[TBL] [Abstract][Full Text] [Related]
11. NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.
Siddique HR; Feldman DE; Chen CL; Punj V; Tokumitsu H; Machida K
Hepatology; 2015 Nov; 62(5):1466-79. PubMed ID: 26174965
[TBL] [Abstract][Full Text] [Related]
12. Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells.
Elrick MM; Samson WK; Corbett JA; Salvatori AS; Stein LM; Kolar GR; Naatz A; Yosten GL
Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(2):R143-55. PubMed ID: 26561648
[TBL] [Abstract][Full Text] [Related]
13. Evidence for an interaction of neuronostatin with the orphan G protein-coupled receptor, GPR107.
Yosten GL; Redlinger LJ; Samson WK
Am J Physiol Regul Integr Comp Physiol; 2012 Nov; 303(9):R941-9. PubMed ID: 22933024
[TBL] [Abstract][Full Text] [Related]
14. Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer.
Sáez-Martínez P; Jiménez-Vacas JM; León-González AJ; Herrero-Aguayo V; Montero Hidalgo AJ; Gómez-Gómez E; Sánchez-Sánchez R; Requena-Tapia MJ; Castaño JP; Gahete MD; Luque RM
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32498336
[TBL] [Abstract][Full Text] [Related]
15. Deficits in receptor-mediated endocytosis and recycling in cells from mice with Gpr107 locus disruption.
Zhou GL; Na SY; Niedra R; Seed B
J Cell Sci; 2014 Sep; 127(Pt 18):3916-27. PubMed ID: 24849652
[TBL] [Abstract][Full Text] [Related]
16. miR-96 regulates liver tumor-initiating cells expansion by targeting TP53INP1 and predicts Sorafenib resistance.
Huang Y; Zhang J; Li H; Peng H; Gu M; Wang H
J Cancer; 2020; 11(22):6545-6555. PubMed ID: 33046975
[TBL] [Abstract][Full Text] [Related]
17. Changes in expression of orphan receptors GPR99 and GPR107 during the development and establishment of hypertension in spontaneously hypertensive rats.
Calderón-Zamora L; Canizalez-Román A; León-Sicairos N; Aguilera-Mendez A; Huang F; Hong E; Villafaña S
J Recept Signal Transduct Res; 2021 Dec; 41(6):558-565. PubMed ID: 33121311
[TBL] [Abstract][Full Text] [Related]
18. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
[TBL] [Abstract][Full Text] [Related]
19. The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells.
Liang Z; Wu B; Ji Z; Liu W; Shi D; Chen X; Wei Y; Jiang J
Cancer Lett; 2021 Aug; 513():90-100. PubMed ID: 33984420
[TBL] [Abstract][Full Text] [Related]
20. PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.
Wang Y; Hill KS; Fields AP
Mol Cancer Res; 2013 Dec; 11(12):1624-35. PubMed ID: 24174471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
